1. Home
  2. GOSS vs MTW Comparison

GOSS vs MTW Comparison

Compare GOSS & MTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • MTW
  • Stock Information
  • Founded
  • GOSS 2015
  • MTW 1902
  • Country
  • GOSS United States
  • MTW United States
  • Employees
  • GOSS N/A
  • MTW N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • MTW Construction/Ag Equipment/Trucks
  • Sector
  • GOSS Health Care
  • MTW Industrials
  • Exchange
  • GOSS Nasdaq
  • MTW Nasdaq
  • Market Cap
  • GOSS 347.8M
  • MTW 358.5M
  • IPO Year
  • GOSS 2019
  • MTW N/A
  • Fundamental
  • Price
  • GOSS $2.47
  • MTW $9.89
  • Analyst Decision
  • GOSS Strong Buy
  • MTW Hold
  • Analyst Count
  • GOSS 4
  • MTW 4
  • Target Price
  • GOSS $8.50
  • MTW $11.00
  • AVG Volume (30 Days)
  • GOSS 3.1M
  • MTW 381.2K
  • Earning Date
  • GOSS 08-05-2025
  • MTW 08-07-2025
  • Dividend Yield
  • GOSS N/A
  • MTW N/A
  • EPS Growth
  • GOSS N/A
  • MTW 436.41
  • EPS
  • GOSS N/A
  • MTW 1.26
  • Revenue
  • GOSS $40,237,000.00
  • MTW $2,131,200,000.00
  • Revenue This Year
  • GOSS N/A
  • MTW N/A
  • Revenue Next Year
  • GOSS $30.65
  • MTW $4.66
  • P/E Ratio
  • GOSS N/A
  • MTW $7.86
  • Revenue Growth
  • GOSS N/A
  • MTW N/A
  • 52 Week Low
  • GOSS $0.66
  • MTW $7.06
  • 52 Week High
  • GOSS $2.65
  • MTW $13.62
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 68.08
  • MTW 38.48
  • Support Level
  • GOSS $2.38
  • MTW $9.91
  • Resistance Level
  • GOSS $2.65
  • MTW $10.19
  • Average True Range (ATR)
  • GOSS 0.15
  • MTW 0.35
  • MACD
  • GOSS 0.03
  • MTW 0.08
  • Stochastic Oscillator
  • GOSS 76.67
  • MTW 61.07

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About MTW Manitowoc Company Inc. (The)

Manitowoc Co Inc provides engineered lifting solutions. It designs and manufactures mobile telescopic cranes, tower cranes, lattice-boom crawler cranes, and boom trucks. It offers products under brand names such as Grove, Manitowoc, National Crane, Potain, Shuttlelift, and Manitowoc Crane Care. Its crane products serve dealers, rental companies, contractors, and government entities in diverse markets, including energy production/distribution and utility, petrochemical and industrial, infrastructure, and commercial/residential construction. Manitowoc has three reportable segments: the Americas, Europe and Africa, and the Middle East and Asia-Pacific. The Americas segment generates the majority of the revenue for the company.

Share on Social Networks: